Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.)
- Affiliations
-
- 1Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 2Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea
- KMID: 2537297
- DOI: http://doi.org/10.3803/EnM.2022.1596
Cited by 3 articles
-
2023 Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules
Young Joo Park, Eun Kyung Lee, Young Shin Song, Soo Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung-Kuk Baek, So Won Oh, Min Kyoung Lee, Sang-Woo Lee, Young Ah Lee, Yong Sang Lee, Ji Ye Lee, Dong-Jun Lim, Leehi Joo, Yuh-Seog Jung, Chan Kwon Jung, Yoon Young Cho, Yun Jae Chung, Won Bae Kim, Ka Hee Yi, Ho-Cheol Kang, Do Joon Park
Int J Thyroidol. 2023;16(1):1-31. doi: 10.11106/ijt.2023.16.1.1.Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules 2024
Young Joo Park, Eun Kyung Lee, Young Shin Song, Su Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung-Kuk Baek, So Won Oh, Min Kyoung Lee, Sang-Woo Lee, Young Ah Lee, Yong Sang Lee, Ji Ye Lee, Dong-Jun Lim, Leehi Joo, Yuh-Seog Jung, Chan Kwon Jung, Yoon Young Cho, Yun Jae Chung, Won Bae Kim, Ka Hee Yi, Ho-Cheol Kang, Do Joon Park
Int J Thyroidol. 2024;17(1):208-244. doi: 10.11106/ijt.2024.17.1.208.Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 5. Evaluation of Recurrence Risk Postoperatively and Initial Risk Stratification in Differentiated Thyroid Cancer 2024
Eun Kyung Lee, Young Shin Song, Ho-Cheol Kang, Sun Wook Kim, Dong Gyu Na, Shin Je Moon, Dong-Jun Lim, Kyong Yeun Jung, Yun Jae Chung, Chan Kwon Jung, Young Joo Park
Int J Thyroidol. 2024;17(1):68-96. doi: 10.11106/ijt.2024.17.1.68.
Reference
-
1. Yang H, Park H, Ryu HJ, Heo J, Kim JS, Oh YL, et al. Frequency of TERT promoter mutations in real-world analysis of 2,092 thyroid carcinoma patients. Endocrinol Metab (Seoul). 2022; 37:652–63.2. Kim SY, Kim T, Kim K, Bae JS, Kim JS, Jung CK. Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans. J Pathol Transl Med. 2020; 54:310–7.
Article3. Choi YS, Choi SW, Yi JW. Prospective analysis of TERT promoter mutations in papillary thyroid carcinoma at a single institution. J Clin Med. 2021; 10:2179.
Article4. Lee J, Ha EJ, Roh J, Kim HK. Presence of TERT±BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma. Surgery. 2021; 170:743–7.5. Bae JS, Kim Y, Jeon S, Kim SH, Kim TJ, Lee S, et al. Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation. Diagn Pathol. 2016; 11:21.
Article
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.)
- Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients
- Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E
- Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
- Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
